# Novel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report

**Authors:** Valentina Giansante, Luca Di Angelo, Chiara Calabrese, Paolo De Sanctis, Paolo Regi, Filippo Maria Martelli, Gianmarco Stati, Rossano Lattanzio, Saverio Alberti, Emanuela Guerra, Roberta Di Pietro

PMC · DOI: 10.3390/ijms25084313 · International Journal of Molecular Sciences · 2024-04-13

## TL;DR

This case report provides new ultrastructural insights into a rare and aggressive form of pancreatic cancer called clear-cell carcinoma.

## Contribution

The study reveals that disrupted mitochondria are linked to the clear-cell nature of this cancer subtype.

## Key findings

- The tumor cells showed a clear-cell appearance with abundant intracytoplasmic vacuoles.
- Transmission electron microscopy revealed a massive presence of structurally disrupted mitochondria.
- Negative staining for NDUFA4L2 suggests a specific molecular characteristic of the tumor.

## Abstract

Pancreatic cancer, most frequently as ductal adenocarcinoma (PDAC), is the third leading cause of cancer death. Clear-cell primary adenocarcinoma of the pancreas (CCCP) is a rare, aggressive, still poorly characterized subtype of PDAC. We report here a case of a 65-year-old male presenting with pancreatic neoplasia. A histochemical examination of the tumor showed large cells with clear and abundant intracytoplasmic vacuoles. The clear-cell foamy appearance was not related to the hyperproduction of mucins. Ultrastructural characterization with transmission electron microscopy revealed the massive presence of mitochondria in the clear-cell cytoplasm. The mitochondria showed disordered cristae and various degrees of loss of structural integrity. Immunohistochemistry staining for NADH dehydrogenase [ubiquinone] 1 alpha subcomplex, 4-like 2 (NDUFA4L2) proved specifically negative for the clear-cell tumor. Our ultrastructural and molecular data indicate that the clear-cell nature in CCCP is linked to the accumulation of disrupted mitochondria. We propose that this may impact on the origin and progression of this PDAC subtype.

## Linked entities

- **Genes:** COXFA4L2 (cytochrome c oxidase hypoxia associated subunit FA4L2) [NCBI Gene 56901]
- **Diseases:** pancreatic cancer (MONDO:0005192), ductal adenocarcinoma (MONDO:0005590)

## Full-text entities

- **Genes:** COXFA4L2 (cytochrome c oxidase hypoxia associated subunit FA4L2) [NCBI Gene 56901] {aka MISTRH, NDUFA4L2, NUOMS}
- **Diseases:** PDAC (MESH:C537768), Clear-cell primary adenocarcinoma of the pancreas (MESH:D018262), Pancreatic cancer (MESH:D010190), ductal adenocarcinoma (MESH:D000230), Clear-Cell Carcinoma of the Pancreas (MESH:D021441), clear-cell tumor (MESH:D002292), cancer (MESH:D009369)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11049960/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11049960/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC11049960/full.md

---
Source: https://tomesphere.com/paper/PMC11049960